BOVILIS® cattle vaccines from Merck Animal Health have you covered. Solutions for respiratory, clostridial, reproductive, mastitis and more.
Cattle News Merck Animal Health Introduces SENSEHUB® Cow Calf Read The only pour-on NSAID for cattle now approved for control of fever due to mastitis Read SenseHub® Feedlot’s Electronic Ear Tag Technology Detects Sick Cattle Earlier, More Accurately ...
Cattle News Merck Animal Health Introduces SENSEHUB® Cow Calf Read The only pour-on NSAID for cattle now approved for control of fever due to mastitis Read SenseHub® Feedlot’s Electronic Ear Tag Technology Detects Sick Cattle Earlier, More Accurately ...
Merck Animal Health collaborates with Rapid Genomics for exclusive rights to a vaccination verification tool, Viral Flex-Seq®, for use in combination with INNOVAX®vaccines, to optimize and enhance disease outbreak management in poultry.
Acquisition of a privately held business focused on the development and manufacture of vaccines for food production and companion animals Acquisition of a previous Merck Animal Health Ventures investment; accelerates the SenseHub Feedlot offering
Virtual fencing system provides advanced technology tocattle producers and ranchers to manage natural resources more effectively Complements Merck Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and animal intelligence solutions
Cattle implants trusted industry wide for beef cattle implants that improve productivity and revenue making efficient use of resources.
Merck's animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted $1.28 billion in sales, up 4% from the same period a year ago. The company said higher demand for companion animal products, such as the flea and tick treatment Bravecto, drove the incre...
BRAVECTO® (fluralaner) chews Flavored chews for dogs U.S. Patent No 7,662,972 U.S. Patent No 8,022,089 U.S. Patent No 8,492,311 U.S. Patent 11,285,101 BOVILIS Nasalgen 3 PMH Live cattle vaccine U.S. Patent No. 9,642,905 ...
China. But to me, at this point, that will be upside for the Company. And beyond that, the breadth of what we have will drive the growth in oncology, in Animal Health and with our new launches. To the vaccines business more broadly, we continue to believe in vaccines as an important...